• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角膜移植术后失败的处理方法:选择与结果。

Corneal transplantation after failed grafts: Options and outcomes.

机构信息

Cornea, Cataract and Refractive Surgery Unit, Vissum (Miranza Group), Alicante, Spain; Division of Ophthalmology, Universidad Miguel Hernández, Alicante, Spain.

Cornea Unit, Guy's & St Thomas' Hospital, London, UK.

出版信息

Surv Ophthalmol. 2021 Jan-Feb;66(1):20-40. doi: 10.1016/j.survophthal.2020.10.003. Epub 2020 Oct 14.

DOI:10.1016/j.survophthal.2020.10.003
PMID:33065176
Abstract

Corneal transplantation is the most commonly performed human tissue transplantation procedure worldwide. Because of the large number of transplants, corneal graft failure has become one of the most common indications for corneal transplantation. The relatively recently developed lamellar transplant techniques have brought about specific potential complications leading to graft failure that may require different approaches to repeat transplantation other than penetrating keratoplasty. On the other hand, these new lamellar techniques also provide novel ways of rescuing failed penetrating grafts, with potential advantages over successive penetrating keratoplasties, such as reduced intraoperative risks and faster visual rehabilitation. We summarize the incidence and risk factors of graft failure for penetrating and lamellar (stromal and endothelial) corneal transplants and discuss the various surgical alternatives currently available to rescue such failed grafts, with a focus on the reported outcomes and limitations.

摘要

角膜移植是全球最常见的人类组织移植手术。由于移植数量众多,角膜移植物失功已成为角膜移植最常见的适应证之一。相对较新的板层移植技术带来了一些特定的潜在并发症,导致移植物失功,这可能需要不同于穿透性角膜移植术的再次移植方法。另一方面,这些新的板层技术也为挽救失败的穿透性移植物提供了新的途径,与连续的穿透性角膜移植术相比具有潜在优势,例如术中风险降低和更快的视力康复。我们总结了穿透性和板层(基质和内皮)角膜移植的移植物失功发生率和危险因素,并讨论了目前可用于挽救这些失败移植物的各种手术替代方法,重点介绍了报告的结果和局限性。

相似文献

1
Corneal transplantation after failed grafts: Options and outcomes.角膜移植术后失败的处理方法:选择与结果。
Surv Ophthalmol. 2021 Jan-Feb;66(1):20-40. doi: 10.1016/j.survophthal.2020.10.003. Epub 2020 Oct 14.
2
Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.现代板层角膜移植术(DALK、DSAEK、DMEK)与传统穿透性角膜移植术后的免疫反应。
Prog Retin Eye Res. 2019 Nov;73:100768. doi: 10.1016/j.preteyeres.2019.07.001. Epub 2019 Jul 3.
3
Differential Survival of Penetrating and Lamellar Transplants in Management of Failed Corneal Grafts.穿透性和板层移植在处理失败的角膜移植物中的差异生存。
JAMA Ophthalmol. 2018 Aug 1;136(8):859-865. doi: 10.1001/jamaophthalmol.2018.1515.
4
Repeat corneal transplantation in Southern China: Indications, surgical technique, outcomes, and risk factors for repeat keratoplasty failure.中国南方地区重复角膜移植术:适应证、手术技术、结果和重复角膜移植失败的风险因素。
Indian J Ophthalmol. 2024 May 1;72(Suppl 3):S482-S487. doi: 10.4103/IJO.IJO_3333_23. Epub 2024 Apr 20.
5
Graft Failure after PKP and DMEK: What is the Best Option?PKP 和 DMEK 术后移植物失功:最佳选择是什么?
Klin Monbl Augenheilkd. 2022 Jun;239(6):775-785. doi: 10.1055/a-1774-4862. Epub 2022 Apr 29.
6
[Penetrating keratoplasty].穿透性角膜移植术
J Fr Ophtalmol. 2022 May;45(5):543-558. doi: 10.1016/j.jfo.2021.11.001. Epub 2022 Mar 14.
7
Current indications and surgical approaches to corneal transplants at the University of Toronto: A clinical-pathological study.多伦多大学角膜移植的当前适应症和手术方法:一项临床病理研究。
Can J Ophthalmol. 2017 Feb;52(1):74-79. doi: 10.1016/j.jcjo.2016.07.005. Epub 2016 Sep 7.
8
Trends in corneal transplantation in a single center in Barcelona, Spain. Transitioning to DMEK.西班牙巴塞罗那单一中心的角膜移植趋势。向 Descemet 膜内皮角膜移植术(DMEK)过渡。
J Fr Ophtalmol. 2020 Jan;43(1):1-6. doi: 10.1016/j.jfo.2019.06.026. Epub 2019 Dec 9.
9
Impact of new lamellar techniques of keratoplasty on eye bank activity.新型角膜移植板层技术对眼库工作的影响。
Graefes Arch Clin Exp Ophthalmol. 2007 Jan;245(1):32-8. doi: 10.1007/s00417-006-0390-7. Epub 2006 Aug 10.
10
Changing indications and surgical techniques for corneal transplantation between 2004 and 2009 at a tertiary referral center.2004年至2009年期间,某三级转诊中心角膜移植的适应证及手术技术变化情况。
Middle East Afr J Ophthalmol. 2012 Jul-Sep;19(3):323-9. doi: 10.4103/0974-9233.97941.

引用本文的文献

1
[Penetrating keratoplasty postoperative conversion after deep anterior lamellar keratoplasty (DALK)].[深板层角膜移植术(DALK)后穿透性角膜移植术的术后转变]
Ophthalmologie. 2025 Sep;122(9):746-749. doi: 10.1007/s00347-025-02272-0. Epub 2025 Aug 14.
2
Deciphering mitochondrial dysfunction in keratoconus: Insights into ACSL4 from machine learning-based bulk and single-cell transcriptome analyses and experimental validation.圆锥角膜中线粒体功能障碍的解析:基于机器学习的批量和单细胞转录组分析及实验验证对ACSL4的深入洞察。
Comput Struct Biotechnol J. 2025 May 14;27:1962-1974. doi: 10.1016/j.csbj.2025.05.013. eCollection 2025.
3
Fabrication of a 3D Corneal Model Using Collagen Bioink and Human Corneal Stromal Cells.
使用胶原蛋白生物墨水和人角膜基质细胞构建3D角膜模型
J Funct Biomater. 2025 Mar 28;16(4):118. doi: 10.3390/jfb16040118.
4
Clinical characteristics and risk factors for readmission after deep anterior lamellar keratoplasty: a nationwide, cross-sectional, multicenter study.深前板层角膜移植术后再入院的临床特征及危险因素:一项全国性、横断面、多中心研究
BMC Ophthalmol. 2025 Apr 9;25(1):193. doi: 10.1186/s12886-025-04010-1.
5
A historical view of the development of corneal transplantation: from penetrating keratoplasty to selective transplantation of the finest corneal layers.角膜移植发展的历史回顾:从穿透性角膜移植到最精细角膜层的选择性移植。
Wien Med Wochenschr. 2025 May;175(7-8):175-185. doi: 10.1007/s10354-025-01077-9. Epub 2025 Apr 1.
6
Exosomes in Corneal Homeostasis and Wound Healing.角膜稳态与伤口愈合中的外泌体
Curr Eye Res. 2025 Feb 12:1-9. doi: 10.1080/02713683.2025.2459335.
7
Ten-year outcomes of repeat keratoplasty for optical indications.光学适应症再次角膜移植的十年随访结果
Front Med (Lausanne). 2025 Jan 22;11:1503333. doi: 10.3389/fmed.2024.1503333. eCollection 2024.
8
Drug delivery strategies to improve the treatment of corneal disorders.改善角膜疾病治疗的药物递送策略。
Heliyon. 2025 Jan 10;11(2):e41881. doi: 10.1016/j.heliyon.2025.e41881. eCollection 2025 Jan 30.
9
A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy.一项关于同种异体诱导多能干细胞来源的角膜内皮细胞替代物移植治疗大疱性角膜病变的首次人体临床研究。
Cell Rep Med. 2025 Jan 21;6(1):101847. doi: 10.1016/j.xcrm.2024.101847. Epub 2025 Jan 13.
10
Embryoid body-based differentiation of human-induced pluripotent stem cells into cells with a corneal stromal keratocyte phenotype.人诱导多能干细胞胚体为基础的分化为具有角膜基质成纤维细胞表型的细胞。
BMJ Open Ophthalmol. 2024 Nov 28;9(1):e001828. doi: 10.1136/bmjophth-2024-001828.